Auxilium engages in the global development, marketing, and sales of ethical pharmaceutical products that maintain functionality in an aging male population. Auxilium’s lead product, Testim 1% (testosterone gel) CIII, is indicated for the treatment of hypogonadism. Auxilium's continued focus is to develop/acquire novel molecules with viability in the urological field.